Fundraising FoxMVM Life Science Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Optinose is a specialty pharmaceutical company that develops and markets products for patients with conditions treated by ear, nose, and throat (ENT) and allergy specialists.
BiotechHealthtechMedical DevicesYardley, US
Per Djupesland(Executive Officer, Director)inMichele Janis(Executive Officer)Peter Miller(Executive Officer, Director)inTerrence Terifay(Executive Officer)Ramy Mahmoud(Executive Officer)in
BoardKlaas De Boer(Director)
Board seatEric BednarskiKyle Dempsey· per SEC Form D
Co-investorsAvistaForesite Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.